calcium oxalate has been researched along with resveratrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KS; Hong, SH; Kim, SH; Ko, HS; Lee, HJ; Shim, BS; Sohn, EJ | 1 |
| Ding, DM; Feng, SY; Tian, QX; Wang, DM; Wang, X; Xie, DD; Ye, QL; Yu, DX; Zhang, ZH; Zhang, ZQ | 1 |
2 other study(ies) available for calcium oxalate and resveratrol
| Article | Year |
|---|---|
Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo.
Topics: Animals; Antioxidants; Calcium Oxalate; Cell Movement; Cell Survival; Cells, Cultured; Chemokine CCL2; Down-Regulation; Ethylene Glycol; Humans; Hyaluronic Acid; Kidney; Kidney Calculi; Male; Malondialdehyde; NADP; NADPH Oxidases; Osteopontin; Oxalic Acid; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Transforming Growth Factors; Wound Healing | 2013 |
Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury.
Topics: Aged; Animals; Apoptosis; Calcium Oxalate; Cell Adhesion; Cell Line; Crystallization; Female; Gene Silencing; Glyoxylates; Humans; Kidney; Kidney Calculi; Mice, Inbred C57BL; Middle Aged; Necrosis; Resveratrol; Sirtuin 1 | 2021 |